z-logo
open-access-imgOpen Access
EPIDEMIOLOGICAL FEATURES OF SARS2 COVID-19 OUTBREAK DURING 2020 AMONG RT-PCR CONFIRMED CASES IN ZAKARPATTYA
Author(s) -
Stepan O Karabinyosh,
Galina Koval
Publication year - 2021
Publication title -
wiadomości lekarskie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.133
H-Index - 14
eISSN - 2719-342X
pISSN - 0043-5147
DOI - 10.36740/wlek202104128
Subject(s) - outbreak , epidemiology , observational study , pandemic , medicine , population , public health , covid-19 , retrospective cohort study , demography , environmental health , disease , virology , pathology , infectious disease (medical specialty) , sociology
The aim: The overall aim of this project was to provide a comprehensive description of epidemiological and demographic features of SARS2 COVID19 outbreak among patients in Zakarpattya oblast during 2020 to define most vulnerable and susceptible groups of population.Materials and methods: We conducted a retrospective observational descriptive study of the 33 190 cases that tested RT-PCR positive for SARS 2 COVI19 in Zakarpattya oblast, studied their comorbidities and concomitant diseases, as well as their clinical and functional outcomes.Results: Among studied cases: females – 20 069 (60.47±0.27%) and males – 13 121 (39.53±0.27%). Geographical distribution showed that: 10 230 (30.8%) of cases were registered in district capital Uzhhorod and surrounding area, 3 646 (11%) were registered in Mukachevo district, Tyachivsky district 3 235 cases (9.7%), Vynohradisky district 2 627 (7.9%), other districts had less than 4 %. Most patients were within the age group 31 and 70 with a mean age of 47.76±17.57 years.Conclusions: the emergence of current outbreak of SARS-CoV-2 (COVID-19) pandemic is a reminder of how new pathogens can mutate, emerge and rapidly spread through large amount of human population, and cause severe burden to public health and healthcare system is general.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here